Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seagen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Six-Year Overall Survival Results Added to U.S. Prescribing Information for ADCETRIS® (brentuximab vedotin) as First-Line Treatment for Advanced Hodgkin Lymphoma
June 14, 2023
From
Seagen Inc.
Via
Business Wire
Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating
June 14, 2023
B Riley Securities has initiated Ambrx Biopharma Inc (NASDAQ: AMAM) with a Buy rating and a
Via
Benzinga
Seagen's Adcetris/Immunotherapy Combo Achieves 98% Overall Response Rate in Early-Stage Lymphoma Setting
June 13, 2023
Seagen Inc (NASDAQ: SGEN) announced updated efficacy and safety results from Part C of phase 2 single-arm trial of Adcetris (brentuximab vedotin) combined with nivolumab and standard chemotherapy...
Via
Benzinga
Seagen Announces ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 98% Overall Response Rate and 93% Complete Response Rate in Patients with Early-Stage Classical Hodgkin Lymphoma (cHL)
June 13, 2023
From
Seagen Inc.
Via
Business Wire
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,800 Today
June 07, 2023
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $4,000 Today
May 23, 2023
Via
Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
3 Stocks Worth Buying at 52-Week Lows
May 30, 2023
Here are three stocks that are trading near their 52-week lows and may be primed for a short-term rally for opportunistic investors
Via
MarketBeat
Seagen Stockholders Approve Acquisition by Pfizer
May 30, 2023
From
Seagen Inc.
Via
Business Wire
Check Out What Whales Are Doing With SGEN
May 18, 2023
Via
Benzinga
(SGEN) - Analyzing Seagen's Short Interest
May 15, 2023
Via
Benzinga
$100 Invested In Seagen 5 Years Ago Would Be Worth This Much Today
May 05, 2023
Via
Benzinga
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
May 24, 2023
Should Pfizer and Seagen investors be worried?
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 23, 2023
Via
Benzinga
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
May 22, 2023
The pharmaceutical giant wouldn't be borrowing if it didn't have plans for how to make a tidy return.
Via
The Motley Fool
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
May 19, 2023
Despite worries about FTC scrutiny, Pfizer remains optimistic about its planned Seagen acquisition, issuing $31 billion in bonds to finance the deal.
Via
MarketBeat
Topics
Bonds
Exposures
Debt Markets
FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal
May 17, 2023
Pfizer Inc (NYSE: PFE) plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc (NASDAQ: SGEN)
Via
Benzinga
Seagen's Return on Invested Capital Insights
May 03, 2023
Via
Benzinga
FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A
May 16, 2023
In a rare move to block a large pharma deal, the U.S.
Via
Benzinga
GDC Stock Alert: Why Is GD Culture Group Up 106% Today?
May 16, 2023
GD Culture (GDC) stock is rocketing higher on Tuesday with investors reacting to the company's earnings report for Q1 2023.
Via
InvestorPlace
Why Is Guardforce AI (GFAI) Stock Up Today?
May 16, 2023
Guardforce AI (GFAI) stock is on the rise Tuesday after the AI company announced the closing of a public share offering.
Via
InvestorPlace
GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?
May 16, 2023
Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares.
Via
InvestorPlace
Seagen (SGEN) Stock Falls 6% After Director Sells Shares
May 16, 2023
Seagen (SGEN) stock is slipping on Tuesday after one of the company's directors sold shares worth more than $372,000 on Monday.
Via
InvestorPlace
Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover
May 16, 2023
Reports the FTC could block Amgen's takeover of Horizon reverberated across biotechs on Tuesday, with HZNP stock's crash leading the way.
Via
Investor's Business Daily
Vaccine Sales Are Falling. Should You Still Buy Pfizer?
May 04, 2023
This is a transition year for Pfizer.
Via
The Motley Fool
7 High-Yield Dividend Stocks to Buy and Hold Forever
April 30, 2023
A stagnant market can be frustrating, but also a good time to look for high-yield dividend stocks to buy now.
Via
InvestorPlace
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
April 28, 2023
Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies.
Via
Investor's Business Daily
Seagen Reports First Quarter 2023 Financial Results
April 27, 2023
From
Seagen Inc.
Via
Business Wire
Earnings Scheduled For April 27, 2023
April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.